1. Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts; and Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands (E.L.F.)
2. Department of Medical Epidemiology and Biostatistics, Karolinska Institute, and Division of Nephrology, Department of Clinical Sciences, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden (J.-J.C.)
3. Optimal Aging Institute and Division of Epidemiology, Department of Population Health, New York University Grossman School of Medicine, New York, New York (Y.S.)
4. Department of Clinical Intervention and Technology, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden (M.E.)
5. Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland (J.I.)
6. Division of Nephrology, Department of Internal Medicine, Tufts Medical Center, Boston, Massachusetts (L.A.I., A.S.L.)
7. Division of Precision Medicine, Department of Medicine, New York University Grossman School of Medicine, New York, New York (M.E.G.)
8. Optimal Aging Institute and Division of Epidemiology, Department of Population Health, New York University Grossman School of Medicine, New York, New York, and Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland (J.C., S.H.B.)